N/A N=39 Fetal and Neonatal Magnetophysiology
Fetal Arrhythmia · Abnormality in Fetal Heart Rate or Rhythm · Long QT Syndrome
Primary: Percentage of Subjects Experiencing Symptoms — 0; 0 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=60 Do Treatments for Smoking Cessation Affect Alcohol Drinking?
Alcohol Drinking
Primary: Number of Drinks Consumed — 2.1; 2.05; 1.5; 1.7 number of drinks
Phase 3 N=125 Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
Refractory Generalized Myasthenia Gravis
Primary: Myasthenia Gravis Activities of Daily Living Profile (MG-ADL): Change From Baseline in MG-ADL Total Score at Week 26 by Worst-Rank Analysis of Covariance (ANCOVA)…
Phase 2 N=25 SMAC Mimetic LCL161 Alone or With Cyclophosphamide in Treating Patients With Relapsed or Refractory Multiple Myeloma
Recurrent Plasma Cell Myeloma · Refractory Plasma Cell Myeloma
Primary: Confirmed Overall Response Rate (Stringent Complete Response [sCR], Complete Response [CR], Very Good Partial Response [VGPR], or Partial Response [PR]) With Single…
Phase 2 N=6 Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Brain and Central Nervous System Tumors · Lymphoma
Primary: Number of Phase I Participants Experiencing Toxicity — 1; 3 Participants
Phase 3 N=734 Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor
Alzheimer's Disease
Primary: Change in Cognition — 0.68; 0.13 units on a scale — p=0.2365
Phase 4 N=60 DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects
HIV
Primary: Primary Efficacy Endpoint for Virologic Suppression in HIV-infected Subjects — 27; 25 participants
Phase 2 N=73 Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer
Pancreatic Acinar Cell Carcinoma · Pancreatic Ductal Adenocarcinoma · Recurrent Pancreatic Carcinoma
Primary: Progression-free Survival Using RECIST v. 1.1 — 4.9; 5.2 months
N/A N=17 Evaluating the Influence of Apnea on Cardiac Function Using Cardiac Magnetic Resonance Imaging.
Physiological Changes in Deliberate Apnea
Primary: Cardiac Function: Duration of Apnea — 483 sec
N/A N=33 Study on the Role of Treatment With Vitamin E on Asthmatic Responses in Allergic Asthmatics
Allergic Asthma
Primary: Effect of Natural-source d-α-tocopheryl Acetate on the Baseline and Allergen-induced Levels of F2-isoprostanes in the Bronchoalveolar Lavage Fluid (BAL)
Phase 2 N=30 Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis
Systemic Sclerosis
Primary: Improvement in the Modified Rodnan Skin Score — -6.6 units on a scale
Phase 2 N=40 Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma
Brain Cancer · Malignant Glioma
Primary: Number of Participants With Adverse Events — 40 Participants
Phase 4 N=67 Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery
Coronary Artery Disease
Primary: Number of Participants With Stress Hyperglycemic Events in the Intensive Care Unit (ICU) — 22; 25 Participants
Phase 4 N=100 Assessing Maternal Post-partum Pain With Suppositories
Pain
Primary: Pain Level Twenty Four Hours After Delivery — 1; 2 units on a scale — p=.35
N/A N=91 A Randomized, Single Centre, Double-blind, Parallel, Sham-controlled Pilot Study Using gammaCore®-G
Dyspepsia · Irritable Bowel Syndrome
Primary: Symptom Changes in Subjects With Functional Gastrointestinal Disorder (Functional Dyspepsia and Irritable Bowel Syndrome) — -0.6; -1.29; -46.84; -40.24 units on a scale